Literature DB >> 6417784

Comparison of cerebral blood flow after venesection of bronchitic secondary polycythaemic and primary polycythaemic patients.

P D Semple, G D Lowe, J Patterson, G H Beastall, J O Rowan, C D Forbes, R Hume.   

Abstract

Cerebral blood flow was measured before and after lowering of haematocrit in four patients with primary polycythaemia and in nine with polycythaemia secondary to chronic obstructive airways disease. Cerebral blood flow values in each group were abnormally low to a similar degree at the start of the study and the degree of rise in cerebral blood flow per unit fall in haematocrit after venesection also was similar in each. Oxygen delivery fell despite increased cerebral blood flow and symptomatic benefit was infrequent. In male secondary polycythaemic patients rise in cerebral blood flow was not associated with any improvement in hypothalamo-pituitary-testicular function which we had previously noted to be suppressed in such hypoxic subjects. Our findings suggest viscosity changes rather than alteration in blood oxygen carriage to be responsible for cerebral blood flow improvement. It is concluded that therapeutic venesection in such patients should be applied with caution.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417784     DOI: 10.1177/003693308302800404

Source DB:  PubMed          Journal:  Scott Med J        ISSN: 0036-9330            Impact factor:   0.729


  2 in total

1.  Spontaneous obliteration of a dural arteriovenous fistula after treatment of polycythemia in a patient with factor V Leiden mutation: case report.

Authors:  J van Beijnum; C J M Klijn; T H Lo; A van der Zwan; L J Kappelle
Journal:  J Neurol       Date:  2010-04-10       Impact factor: 4.849

2.  Cerebral blood flow and cerebral oxygen consumption in patients with COPD on mechanical ventilation.

Authors:  A Sari; S Oshiata; T Toriumi; S Yamashita; S Kojima; S Kakumoto; A Yonei
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.